Abstract

AbstractThe choice of sex in newborns with genital ambiguity is challenging. Information concerning the satisfaction of subjects with disorders of sex development from childhood to adulthood is required in order to address sex attribution policies. This study focuses on the methods that enable clinicians to investigate the alignment of phenotypes with gender identity and quality of life in people with disorders of this kind. These methods are presented as tools for studying a cohort of ten subjects with 45,X/46,XY mosaicism examined between 1985 and 2014 in the Department of Pediatric Endocrinology, Regina Margherita Children's Hospital, Turin: five children and five young adults, four reared as females and six as males. Clinical outcome was assessed by means of a clinical scoring system considering height, genital appearance, gonads and pubertal development. The Gender Identity Questionnaire for Children and the World Health Organization Quality of Life assessment were adopted. The four male children strongly identified with their assigned sex: male attribution was satisfactory until pubertal age. In young adults the clinical scores ranged between 55–65% for both genders. In the young male, the reduced sexual activity and the poor body image perception strongly affected his quality of life. The clinical scores of the two young female adults (60% for both) were not balanced with their quality of life scores (87.5% and 68.75% respectively): individual traits and social-familial context should be investigated in order to explain these differences. Clinical and psychosocial assessment in people with disorders of sex development is mandatory in order to plan care procedures; a detailed analysis requires adequate tools. Clinical scoring system, Gender Identity Questionnaire for Children and World Health Organization Quality of Life assessment can be used to investigate the alignment of physical phenotype with gender identity and quality of life.

Highlights

  • Disorders of Sex Development (DSD) are congenital conditions defined by atypical chromosomal, gonadal or anatomic sex [1]

  • The most recent classification is based on chromosomal setting: DSD related to sex chromosome abnormalities and DSD related to 46,XY or 46,XX karyotype [5]. 45,X/46,XY mosaicism, included in sex chromosome abnormalities DSD, have an overall incidence of about one in 10.000 [6]

  • This study focuses on methods that enable clinicians to investigate the alignment of physical characteristics, gender identity and quality of life in people with DSD

Read more

Summary

Introduction

Disorders of Sex Development (DSD) are congenital conditions defined by atypical chromosomal, gonadal or anatomic sex [1]. 45,X/46,XY mosaicism, included in sex chromosome abnormalities DSD, have an overall incidence of about one in 10.000 [6]. Most prenatally diagnosed subjects (90‒95%) present normal male phenotype at birth; abnormalities are only found in a small percentage (5‒10%) [7,10,11,12]. Typical somatic signs of the Turner syndrome are observed in some cases (palpebral ptosis, epicanthus, webbed neck, short stature, shield chest, scoliosis) with possible prenatal and postnatal growth retardation [10,13]. Gonads can be set at any point of the testicular descent path: streak gonads are found most frequently at intra-abdominal level, while regularly developed testes often reach inguinal-scrotal level [17]. Müllerian structures are occasionally found, resulting from absent or inadequate production of anti-Müllerian hormone by Sertoli cells [12]

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call